Market Currents
Shares of Cadence Pharmaceuticals (CADX +12.0%) jump on news that the company will resubmit its...
-
Monday, April 19, 2010, 10:22 AM ETShares of Cadence Pharmaceuticals (CADX +12.0%) jump on news that the company will resubmit its market application for U.S. approval of its acetaminophen intravenous formulation within 30 days. (PR)
Other date
Latest Articles
